FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082912289> ?p ?o ?g. }

• W2082912289 endingPage "614" @default.
• W2082912289 startingPage "608" @default.
• W2082912289 abstract "✓ The aim of this study was to evaluate the feasibility and efficacy of a protocol that includes “sandwich” chemotherapy, that is, chemotherapy alternated with radiotherapy, and reduced doses of supratentorial irradiation in children with medulloblastoma. Between March 1985 and September 1988, 70 successive children with newly diagnosed medulloblastoma from eight centers were treated in this prospective nonrandomized study. Patients were assigned to two risk groups. Group A included patients with macroscopically complete or subtotal excision, no brainstem involvement, no atypical cells in the cerebrospinal fluid, normal myelography, and who were more than 2 years of age. Group B patients encompassed those who did not fit the criteria for Group A. Two children were excluded from analysis after histological review confirmed ependymoma. Thus, a population of 68 children was selected, with 31 in Group A and 37 in Group B. Treatment consisted of two courses of the “eight drugs in 1 day” (“8/1”) regimen followed by two courses of high-dose methotrexate (12 g/m 2 ). Radiotherapy was begun during the 7th week after surgery in Group A and during the 5th week in Group B. In patients older than 2 years, the median radiation dose to the posterior fossa, the spinal axis, and the brain was 54 Gy, 36 Gy, and 27 Gy, respectively. Group B patients received postirradiation chemotherapy with four 8/1 courses monthly. The median time from surgery to radiation therapy was 50 days (range 21 to 141 days). One fatality due to chicken pox on Day 102 and one World Health Organization Grade IV infection occurred. The estimated 5- and 7-year disease-free survival (DFS) rates were 62% and 59%, respectively. These were 74% and 62% in Group A and 57% and 57% in Group B. Patient age, extent of resection, and radiation dose to the whole brain had no prognostic value. Patients with metastasis had a nonsignificant trend for a worse prognosis than patients with nonmetastatic disease (7-year DFS 45% vs. 68%, p = 0.11). In Group B, the 7-year DFS rates for children who received more or less than 30 Gy to the brain were 69% and 52% respectively (p = 0.15). There were recurrences in the posterior fossa (37%), spine (20%), and brain (20%). After a review of radiotherapeutic treatments, only one supratentorial failure could be blamed on reduction of the supratentorial radiation dose. This “sandwich” chemotherapy appeared to be feasible and did not show adverse survival data when compared to other series." @default.
• W2082912289 created "2016-06-24" @default.
• W2082912289 creator A5005804337 @default.
• W2082912289 creator A5020593337 @default.
• W2082912289 creator A5021039464 @default.
• W2082912289 creator A5027086161 @default.
• W2082912289 creator A5032205769 @default.
• W2082912289 creator A5034534124 @default.
• W2082912289 creator A5037515069 @default.
• W2082912289 creator A5043741022 @default.
• W2082912289 creator A5048970134 @default.
• W2082912289 creator A5049198404 @default.
• W2082912289 creator A5050738358 @default.
• W2082912289 creator A5052648400 @default.
• W2082912289 creator A5068257880 @default.
• W2082912289 creator A5077369264 @default.
• W2082912289 creator A5077528234 @default.
• W2082912289 creator A5085088950 @default.
• W2082912289 creator A5088072053 @default.
• W2082912289 date "1995-04-01" @default.
• W2082912289 modified "2023-10-18" @default.
• W2082912289 title "Preirradiation chemotherapy including “eight drugs in 1 day” regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study" @default.
• W2082912289 cites W1509802320 @default.
• W2082912289 cites W1968652854 @default.
• W2082912289 cites W1971400303 @default.
• W2082912289 cites W1977826988 @default.
• W2082912289 cites W1978161696 @default.
• W2082912289 cites W1986557288 @default.
• W2082912289 cites W2019232415 @default.
• W2082912289 cites W2024980692 @default.
• W2082912289 cites W2027294932 @default.
• W2082912289 cites W2029871845 @default.
• W2082912289 cites W2034622647 @default.
• W2082912289 cites W2042901076 @default.
• W2082912289 cites W2049983595 @default.
• W2082912289 cites W2053165087 @default.
• W2082912289 cites W2053548298 @default.
• W2082912289 cites W2053750512 @default.
• W2082912289 cites W2062033425 @default.
• W2082912289 cites W2069010139 @default.
• W2082912289 cites W2081053304 @default.
• W2082912289 cites W2088337704 @default.
• W2082912289 cites W2092214886 @default.
• W2082912289 cites W2100591282 @default.
• W2082912289 cites W2104996683 @default.
• W2082912289 cites W2133893515 @default.
• W2082912289 cites W2140984300 @default.
• W2082912289 cites W2144119945 @default.
• W2082912289 cites W2147898950 @default.
• W2082912289 cites W2171492359 @default.
• W2082912289 cites W2285560870 @default.
• W2082912289 cites W4238242862 @default.
• W2082912289 cites W4293241248 @default.
• W2082912289 doi "https://doi.org/10.3171/jns.1995.82.4.0608" @default.
• W2082912289 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7897523" @default.
• W2082912289 hasPublicationYear "1995" @default.
• W2082912289 type Work @default.
• W2082912289 sameAs 2082912289 @default.
• W2082912289 citedByCount "72" @default.
• W2082912289 countsByYear W20829122892012 @default.
• W2082912289 countsByYear W20829122892013 @default.
• W2082912289 countsByYear W20829122892014 @default.
• W2082912289 countsByYear W20829122892016 @default.
• W2082912289 countsByYear W20829122892017 @default.
• W2082912289 countsByYear W20829122892019 @default.
• W2082912289 countsByYear W20829122892020 @default.
• W2082912289 countsByYear W20829122892023 @default.
• W2082912289 crossrefType "journal-article" @default.
• W2082912289 hasAuthorship W2082912289A5005804337 @default.
• W2082912289 hasAuthorship W2082912289A5020593337 @default.
• W2082912289 hasAuthorship W2082912289A5021039464 @default.
• W2082912289 hasAuthorship W2082912289A5027086161 @default.
• W2082912289 hasAuthorship W2082912289A5032205769 @default.
• W2082912289 hasAuthorship W2082912289A5034534124 @default.
• W2082912289 hasAuthorship W2082912289A5037515069 @default.
• W2082912289 hasAuthorship W2082912289A5043741022 @default.
• W2082912289 hasAuthorship W2082912289A5048970134 @default.
• W2082912289 hasAuthorship W2082912289A5049198404 @default.
• W2082912289 hasAuthorship W2082912289A5050738358 @default.
• W2082912289 hasAuthorship W2082912289A5052648400 @default.
• W2082912289 hasAuthorship W2082912289A5068257880 @default.
• W2082912289 hasAuthorship W2082912289A5077369264 @default.
• W2082912289 hasAuthorship W2082912289A5077528234 @default.
• W2082912289 hasAuthorship W2082912289A5085088950 @default.
• W2082912289 hasAuthorship W2082912289A5088072053 @default.
• W2082912289 hasBestOaLocation W20829122891 @default.
• W2082912289 hasConcept C141071460 @default.
• W2082912289 hasConcept C142724271 @default.
• W2082912289 hasConcept C2776694085 @default.
• W2082912289 hasConcept C2777785397 @default.
• W2082912289 hasConcept C2778336483 @default.
• W2082912289 hasConcept C2780789225 @default.
• W2082912289 hasConcept C2781059491 @default.
• W2082912289 hasConcept C2781413609 @default.
• W2082912289 hasConcept C2781432949 @default.
• W2082912289 hasConcept C2908647359 @default.
• W2082912289 hasConcept C509974204 @default.
• W2082912289 hasConcept C71924100 @default.

• next